GPR87 Promotes Metastasis through the AKT-eNOS-NO Axis in Lung Adenocarcinoma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Lung adenocarcinoma is a major cause of cancer mortality, with limited treatment options.
• Novel oncogenic mechanisms are needed to improve patient outcomes in lung cancer.
• The role of G protein-coupled receptor 87 (GPR87) in lung adenocarcinoma progression is not well understood.

Purpose of the Study:

• To investigate the role of GPR87 expression in lung adenocarcinoma metastasis.
• To determine the clinical relevance of GPR87 in lung adenocarcinoma patients.
• To elucidate the downstream signaling pathway of GPR87 in lung adenocarcinoma.

Main Methods:

• In vitro and in vivo functional experiments were conducted to assess GPR87's impact on metastasis.
• Public lung adenocarcinoma datasets were analyzed to correlate GPR87 expression with patient prognosis.
• Molecular signaling pathways, including AKT-eNOS-NO, were investigated downstream of GPR87.

Main Results:

• GPR87 expression is significantly upregulated in lung adenocarcinoma tissues.
• Elevated GPR87 levels correlate with poor patient prognosis.
• GPR87 overexpression enhances lung adenocarcinoma cell invasiveness and metastasis.
• The AKT-eNOS-NO signaling pathway was identified as a downstream mediator of GPR87 function.
• Silencing GPR87 suppressed tumor cell metastasis and invasiveness.

Conclusions:

• GPR87 plays an oncogenic role in lung adenocarcinoma progression and metastasis.
• GPR87 promotes metastasis via activation of the eNOS signaling pathway.
• Targeting eNOS represents a potential therapeutic strategy for lung adenocarcinoma.